Search
Descriptor English: Phenacetin
Descriptor Spanish: Fenacetina
Descriptor fenacetina
Entry term(s) acetofenetidina
Scope note: Fenilacetamida que en el pasado se utilizó en una amplia variedad de preparados ANALGÉSICOS. Su implicación en el desarrollo de nefropatías y METAHEMOGLOBINEMIA condujo a su retirada del mercado. (Smith and Reynard, Textbook of Pharmacology,1991, p431).
Descriptor Portuguese: Fenacetina
Descriptor French: Phénacétine
Entry term(s): Acetophenetidin
Tree number(s): D02.065.199.092.700
D02.092.146.113.092.700
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D010615
Scope note: A phenylacetamide that was formerly used in ANALGESICS but nephropathy and METHEMOGLOBINEMIA led to its withdrawal from the market. (From Smith and Reynard, Textbook of Pharmacology,1991, p431)
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Analgesics, Non-Narcotic
Registry Number: ER0CTH01H9
CAS Type 1 Name: Acetamide, N-(4-ethoxyphenyl)-
Public MeSH Note: 65; see ACETOPHENETIDIN 1963-64
History Note: 65(63)
DeCS ID: 27750
Unique ID: D010615
NLM Classification: QV 95
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1965/01/01
Date of Entry: 1999/01/01
Revision Date: 2015/11/24
Phenacetin - Preferred
Concept UI M0016487
Scope note A phenylacetamide that was formerly used in ANALGESICS but nephropathy and METHEMOGLOBINEMIA led to its withdrawal from the market. (From Smith and Reynard, Textbook of Pharmacology,1991, p431)
Preferred term Phenacetin
Entry term(s) Acetophenetidin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey